Floatz logo

135 assets in Type 2 Diabetes Mellitus

Therapeutic assets addressing Type 2 Diabetes Mellitus, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Liraglutide
Type 2 Diabetes Mellitus
RenJi HospitalP4BBB (79)
Cotadutide
Type 2 Diabetes Mellitus
AstraZenecaP2BBB (78)
Dapagliflozin
Type 2 Diabetes Mellitus
Bhavya Bhavya, MDP4BBB (78)
Exenatide
Type 2 Diabetes Mellitus
Vivani Medical, IncP4BBB (78)
Semaglutide
Type 2 Diabetes Mellitus
Shanghai Jiao Tong University School of MedicineP4BBB (78)
Metformin
Type 2 Diabetes Mellitus
Myopharm LimitedP4BBB (76)
Midazolam
Type 2 Diabetes Mellitus
PfizerP4BBB (73)
Orlistat
Type 2 Diabetes Mellitus
Affiliated Hospital of Nantong UniversityP4BBB (73)
Pioglitazone
Type 2 Diabetes Mellitus
Seoul National University Bundang HospitalP4BBB (73)
Testosterone Undecylate
Type 2 Diabetes Mellitus
Alexandra Kautzky-WillerP4BBB (73)
Empagliflozin
Type 2 Diabetes Mellitus
Post Graduate Institute of Medical Education and Research, ChandigarhP4BBB (72)
Gliclazide
Type 2 Diabetes Mellitus
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolP4BBB (72)
Vildagliptin
Type 2 Diabetes Mellitus
Al-Azhar UniversityP4BBB (72)
Alogliptin
Type 2 Diabetes Mellitus
The Fourth Affiliated Hospital of Zhejiang University School of MedicineP4BB (69)
Sitagliptin
Type 2 Diabetes Mellitus
Brigham and Women's HospitalP4BB (69)
Tirzepatide
Type 2 Diabetes Mellitus
Las Rías Medical CenterP4BB (69)
Canagliflozin
Type 2 Diabetes Mellitus
First Affiliated Hospital Xi'an Jiaotong UniversityP4BB (67)
Rosuvastatin
Type 2 Diabetes Mellitus
PfizerP4BB (67)
Glucagon
Type 2 Diabetes Mellitus
Rutgers, The State University of New JerseyP4BB (66)
Aspirin
Type 2 Diabetes Mellitus
Galala UniversityP4BB (65)
Carvedilol
Type 2 Diabetes Mellitus
Post Graduate Institute of Medical Education and Research, ChandigarhP4BB (65)
Aleniglipron
Type 2 Diabetes Mellitus
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure TherapeuticsP3BB (64)
Dulaglutide
Type 2 Diabetes Mellitus
Brigham and Women's HospitalP4BB (64)
Enicepatide
Type 2 Diabetes Mellitus
Hoffmann-La RocheP3BB (64)
Cagrilintide
Type 2 Diabetes Mellitus
Novo Nordisk A/SP3B (62)
Cerebrolysin
Type 2 Diabetes Mellitus
Hospital Universitario Dr. Jose E. GonzalezP4B (62)
nnc0487-0111
Type 2 Diabetes Mellitus
Novo Nordisk A/SP3B (62)
Mifepristone
Type 2 Diabetes Mellitus
Corcept TherapeuticsP4B (61)
Alpha Tocopherol
Type 2 Diabetes Mellitus
Shanghai Jiao Tong University School of MedicineP2B (60)
Ezetimibe
Type 2 Diabetes Mellitus
NewAmsterdam PharmaP3B (60)
Lanifibranor
Type 2 Diabetes Mellitus
Inventiva PharmaP2B (60)
Msdc-0602K
Type 2 Diabetes Mellitus
Cirius Therapeutics, Inc.P3B (60)
Obicetrapib
Type 2 Diabetes Mellitus
NewAmsterdam PharmaP3B (60)
Omeprazole
Type 2 Diabetes Mellitus
PfizerP2B (60)
Orforglipron
Type 2 Diabetes Mellitus
Eli Lilly and CompanyP3B (60)
Survodutide
Type 2 Diabetes Mellitus
Boehringer IngelheimP3B (60)
Clinisol 15%
Type 2 Diabetes Mellitus
Mayo ClinicP4B (59)
Dextrose
Type 2 Diabetes Mellitus
Mayo ClinicP4B (59)
Henagliflozin
Type 2 Diabetes Mellitus
Xiqiao ZhouP4B (59)
Physiologic Sodium Chloride Solution
Type 2 Diabetes Mellitus
Cambridge University Hospitals NHS Foundation TrustP4B (59)
Retatrutide
Type 2 Diabetes Mellitus
Eli Lilly and CompanyP3B (59)
Saroglitazar
Type 2 Diabetes Mellitus
Zydus Lifesciences LimitedP4B (59)
Linagliptin
Type 2 Diabetes Mellitus
Zhujiang HospitalP4B (58)
ct-868
Type 2 Diabetes Mellitus
Carmot Therapeutics, Inc.P2B (57)
htd1801
Type 2 Diabetes Mellitus
HighTide Biopharma Pty LtdP2B (57)
Maridebart Cafraglutide
Type 2 Diabetes Mellitus
AmgenP2B (57)
Mazdutide
Type 2 Diabetes Mellitus
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolP3B (57)
met097
Type 2 Diabetes Mellitus
PfizerP2B (57)
Clofutriben
Type 2 Diabetes Mellitus
Sparrow PharmaceuticalsP2CCC (55)
Nicorandil
Type 2 Diabetes Mellitus
Tanta UniversityP2/3CCC (55)
Showing 1 to 50 of 135 assets
PreviousPage 1 of 3Next